CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Other disposition 10% owner disposed of 3,822 shares (other)
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market buy 10% owner bought 1,150,000 shares at $0.21 ($243,455)
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 8-K Event Material agreement · Other events
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-1MEF Other S-1MEF
Page 1 of 19 · 363 filings